Baker Hughes reported a 36.9% absolute emissions reduction in scope 1 and 2 greenhouse gas (GHG) emissions compared to its 2019 baseline, marking the largest emissions reduction to date, according to its latest sustainability report released Tuesday.
Aetna®, a CVS Health® company (NYSE: CVS), is setting the pace for prior authorization reform, moving faster and further to simplify access to care for patients and providers.
Emmanuel Guilhamon, vice president, Sustainability, Rockwell Automation is a featured guest this week on the Impact Podcast with John Shegerian. The podcast has featured over 2,000 guests who all share in common a passion for making our world a better place on a daily basis.
The MetroHealth Foundation celebrated a $1.5 million investment from the KeyBank Foundation supporting the continued growth and impact of MetroHealth’s Opportunity Centers in Cleveland’s Buckeye and Clark‑Fulton neighborhoods.
Engage for Good announced the winners of the 2026 Halo Awards, recognizing 28 recipients for outstanding corporate–nonprofit partnerships that delivered measurable social impact in 2025. Leading this year’s is FedEx and Orbis International who were named Best of the Best.
At the center of this shift is the convergence of robotic process automation (RPA), intelligent automation and agentic AI — technologies that are redefining both operational efficiency and workforce strategy.
This year's report highlights a key point: inclusion isn't just an afterthought for GoDaddy, which exists to help small businesses and entrepreneurs launch and grow their ventures; it plays an integral part in how we put our purpose into action.
ISO 14001 has officially been updated as of April 2026. The revision introduces several important updates that reflect how environmental and business expectations have evolved over the past decade.
Suazo Business Center, a Utah‑based nonprofit focused on economic empowerment through entrepreneurship, has been awarded a $600,000 grant from the KeyBank Foundation to support the expansion of its entrepreneurship programming.
New treatments take years of research, clinical trials, and regulatory review before reaching patients. Several therapies approaching FDA decisions this spring could expand treatment options for people managing a range of conditions.